Miscellaneous Metabolic Disorders
Gene: DHCR7
Well-established gene-disease association (see OMIM entry). Smith-Lemli-Opitz syndrome is classified as a metabolic disorder by the NIH GARD (https://rarediseases.info.nih.gov/diseases/diseases-by-category/14/metabolic-disorders), and is an inborn error of sterol metabolism.
Sources: NHS GMSCreated: 3 Feb 2021, 2:45 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Smith-Lemli-Opitz syndrome MIM#270400; Disorders of sterol biosynthesis
Publications
Variants in this GENE are reported as part of current diagnostic practice
Well reported to cause SLOSCreated: 18 May 2020, 3:32 a.m. | Last Modified: 18 May 2020, 3:32 a.m.
Panel Version: 0.2825
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Smith-Lemli-Opitz syndrome (MIM#270400)
Publications
Gene: dhcr7 has been classified as Green List (High Evidence).
Gene: dhcr7 has been classified as Green List (High Evidence).
gene: DHCR7 was added gene: DHCR7 was added to Miscellaneous Metabolic Disorders. Sources: NHS GMS Mode of inheritance for gene: DHCR7 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: DHCR7 were set to 7560069; 9634533 Phenotypes for gene: DHCR7 were set to Smith-Lemli-Opitz syndrome MIM#270400; Disorders of sterol biosynthesis Review for gene: DHCR7 was set to GREEN gene: DHCR7 was marked as current diagnostic